-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, ErZk6zXTyLx1BI2Yc+XfUTRMGAZhl7xXHKOhC+pOEp++62yh5tIsiyxzkMKmC3NR JtOuO7c8nyn75HKoHTo2eQ== 0001247741-04-000024.txt : 20040322 0001247741-04-000024.hdr.sgml : 20040322 20040322140913 ACCESSION NUMBER: 0001247741-04-000024 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20040318 FILED AS OF DATE: 20040322 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: LIGAND PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000886163 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 770160744 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 10275 SCIENCE CENTER DRIVE CITY: SAN DIEGO STATE: CA ZIP: 92121-1117 BUSINESS PHONE: 8585507500 MAIL ADDRESS: STREET 1: 10275 SCIENCE CENTER DRIVE CITY: SAN DIEGO STATE: CA ZIP: 92121-1117 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: PETTTIT WILLIAM A CENTRAL INDEX KEY: 0001182617 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-20720 FILM NUMBER: 04681986 BUSINESS ADDRESS: STREET 1: C/O LIGAND PHARMACEUTICALS INC., STREET 2: 10275 SCIENCE CENTER DR. CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 8585507577 MAIL ADDRESS: STREET 1: C/O LIGAND PHARMACEUTICALS INC., STREET 2: 10275 SCIENCE CENTER DR. CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 edgardoc.xml PRIMARY DOCUMENT X0201 4 2004-03-18 0 0000886163 LIGAND PHARMACEUTICALS INC LGND 0001182617 PETTTIT WILLIAM A C/O LIGAND PHARMACEUTICALS INC., 10275 SCIENCE CENTER DR. SAN DIEGO CA 92121 0 1 0 0 Sr. V-P, HR and Administration Common Stock 2004-03-18 4 M 0 10000 9.3125 A 10511 D Common Stock 2004-03-18 4 S 0 10000 18.5215 D 511 D Common Stock 2004-03-18 4 M 0 10000 9.25 A 10511 D Common Stock 2004-03-18 4 S 0 10000 18.5215 D 511 D Employee Stock Option (right to buy) 9.25 2004-03-18 4 M 0 10000 D 2013-04-29 Common Stock 10000 40000 D Employee Stock Option (right to buy) 9.3125 2004-03-18 4 M 0 10000 D 2008-10-01 Common Stock 10000 7470 D The transaction is the exercise of a derivative security. No price applies. Grant to reporting person of options, exercisable over a 4-year period measured from the date of grant, 12-1/2% after six months, then 1/48th of the Option Shares per month thereafter. The date of grant is 4/29/03. Grant to reporting person of options, exercisable over a 4-year period measured from the date of grant, 12-1/2% after six months, then 1/48th of the Option Shares per month thereafter. The date of grant is 10/1/98. The Amount of Securities Beneficially Owned Following Reported Transaction(s) includes a total of 253 shares acquired under the Ligand employee stock purchase plan on 6/30/03, 9/30/03, and 12/31/03. By: Barbara J. Olson For: Willliam A. Pettit 2004-03-22 -----END PRIVACY-ENHANCED MESSAGE-----